Amphiregulin

Amphiregulin

Amphiregulin Molekülinformation

Molecule Name
Amphiregulin
Molekülalias
AR, AREGB, CRDGF, SDGF
Drug Development Progress
Anzahl der klinischen Arzneimittel2
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 1 Clinical
Target-Alias
AREGB,Colorectum cell-derived growth factor,AR,Schwannoma-Derived Growth Factor,Amphiregulin B,CRDGF,SDGF,SDGF GN
Molekülhintergrund
Amphiregulin (AREG), which acts as one of the ligands for epidermal receptor growth factor receptor (EGFR), plays a crucial role in tissue repair, inflammation, and immunity. It is an autocrine growth factor as well as a mitogen for astrocytes, Schwann cells and fibroblasts. It is related to epidermal growth factor (EGF) and transforming growth factor alpha (TGF-alpha). The protein interacts with the EGF/TGF-alpha receptor to promote the growth of normal epithelial cells, and it inhibits the growth of certain aggressive carcinoma cell lines. It also functions in mammary gland, oocyte and bone tissue development. This gene is associated with a psoriasis-like skin phenotype, and is also associated with other pathological disorders, including various types of cancers and inflammatory conditions. [provided by RefSeq, Apr 2014]

Amphiregulin Produktliste

Species
  • Human(2)
Tag
  • His Tag & Avi Tag(2)
Host
  • HEK293(2)
Conjugate
  • Biotin-labeled(2)
Grade
  • RUO(2)
Low Endotoxin
  • No(2)
MoleculeCat. No.Product NameArtHostStructurePurityActivitySize&PriceAdd to Cart
Amphiregulin
Avitag
AMN-H82Q3
Biotinylated Human Amphiregulin Protein, His,Avitag™
Human
HEK293
SDS-PAGE
ELISA

$360.00

25ug
Amphiregulin
Avitag
AMN-H82Q4
Biotinylated Human Amphiregulin Protein, His,Avitag™ (HPLC verified)
Human
HEK293
HPLCSDS-PAGE

$360.00

25ug
You Have Viewed 1-2 Of 2 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
SRN-001SRN-001Phase 1 ClinicalsiRNAgen Therapeutics Inc
Metabolic Dysfunction-Associated Steatotic Liver Disease; Idiopathic Pulmonary Fibrosis; Chronic Kidney Disease-Mineral and Bone Disorder
Details
PMG-1015PMG-1015Phase 1 ClinicalPulmongene Ltd
Idiopathic Pulmonary Fibrosis
Details
Customer Reviews